1.Liver transplantation in patients with fulminant hepatitis B: experience in Canton, China.
Xiaofeng ZHU ; Guihua CHEN ; Xiaoshun HE ; Minqiang LU ; Guodong WANG ; Changjie CAI ; Yang YANG ; Jiefu HUANG
Chinese Medical Sciences Journal 2002;17(1):44-46
OBJECTIVETo investigate the effect of orthotopic liver transplantation on fulminant hepatitis B and the preventive efficiency of lamivudine on recurrence of hepatitis B in China.
PATIENTS AND METHODSTen patients with fulminant hepatitis B received orthotopic liver transplantation under veno-venous bypass. All patients had preoperatively serious jaundice, ascites and coagulopathy, and of whom 7 with encephalopathy, 2 with acute renal failure, and 1 with gastro-hemorrhage. RUSULT: Seven of the 10 patients have survived for 3 approximately 18 months, but 3 died of multi-organ failure or recurrence of fulminant hepatitis B. Seven survivors took lamivudine and 6 of them have survived for 3 approximately 18 months without the signs of recurrence of hepatitis B.
CONCLUSIONOrthotopic liver transplantation is an effective therapy for fulminant hepatitis B, and lamivudine may prevent recurrence of hepatitis B after transplantation.
Adult ; Hepatic Encephalopathy ; drug therapy ; etiology ; surgery ; Hepatitis B ; complications ; drug therapy ; surgery ; Humans ; Lamivudine ; therapeutic use ; Liver Transplantation ; Male ; Middle Aged ; Recurrence ; Survival Rate
2.Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group.
Chinese Journal of Hepatology 2009;17(1):78-80
Acute Disease
;
Bacterial Infections
;
prevention & control
;
Brain Edema
;
drug therapy
;
etiology
;
Critical Care
;
Hepatic Encephalopathy
;
etiology
;
therapy
;
Humans
;
Intracranial Hypertension
;
etiology
;
therapy
;
Liver Failure, Acute
;
etiology
;
nursing
;
therapy
;
Liver Transplantation
;
nursing
;
standards
3.Ascites, Hepatorenal Syndrome and Spontaneous Bacterial Peritonitis in Patients with Portal Hypertension.
The Korean Journal of Gastroenterology 2010;56(3):168-185
Ascites, hepatic encephalopathy and variceal hemorrhage are three major complications of portal hypertension. The diagnostic evaluation of ascites involves an assessment of its etiology by determining the serum-ascites albumin gradient and the exclusion of spontaneous bacterial peritonitis. Ascites is primarily related to an inability to excrete an adequate amount of sodium into urine, leading to a positive sodium balance. Sodium restriction and diuretic therapy are keys of ascites control. But, with the case of refractory ascites, large volume paracentesis and transjugular portosystemic shunts are required. In hepatorenal syndrome, splanchnic vasodilatation with reduction in effective arterial volume causes intense renal vasoconstriction. Splanchnic and/or peripheral vasoconstrictors with albumin infusion, and renal replacement therapy are only bridging therapy. Liver transplantation is the only definitive modality of improving the long term prognosis.
Anti-Bacterial Agents/therapeutic use
;
Ascites/complications/*diagnosis/therapy
;
Bacterial Infections/*diagnosis
;
Hepatic Encephalopathy/complications
;
Hepatorenal Syndrome/complications/*diagnosis/therapy
;
Humans
;
Hypertension, Portal/*complications
;
Liver Transplantation
;
Peritonitis/*diagnosis/drug therapy/etiology
;
Serum Albumin/administration & dosage
4.Metronidazole-induced encephalopathy in a patient with liver cirrhosis.
Hyeong Cheol CHEONG ; Taek Geun JEONG ; Young Bum CHO ; Bong Joon YANG ; Tae Hyeon KIM ; Haak Cheoul KIM ; Eun Young CHO
The Korean Journal of Hepatology 2011;17(2):157-160
Encephalopathy is a disorder characterized by altered brain function, which can be attributed to various causes. Encephalopathy associated with metronidazole administration occurs rarely and depends on the cumulative metronidazole dose, and most patients with this condition recover rapidly after discontinuation of therapy. Because metronidazole is metabolized in the liver and can be transported by the cerebrospinal fluid and cross the blood-brain barrier, it may induce encephalopathy even at a low cumulative dose in patients with hepatic dysfunction. We experienced a patient who showed ataxic gait and dysarthric speech after receiving metronidazole for the treatment of hepatic encephalopathy that was not controlled by the administration of lactulose. The patient was diagnosed as metronidazole-induced encephalopathy, and stopping drug administration resulted in a complete recovery from encephalopathy. This case shows that caution should be exercised when administering metronidazole because even a low dose can induce encephalopathy in patients with liver cirrhosis.
Anti-Infective Agents/*adverse effects/therapeutic use
;
Brain Diseases/*chemically induced/diagnosis
;
Hepatic Encephalopathy/*drug therapy/etiology
;
Humans
;
Liver Cirrhosis/*complications
;
Magnetic Resonance Imaging
;
Male
;
Metronidazole/*adverse effects/therapeutic use
;
Middle Aged
;
Tomography, X-Ray Computed